IL6 and pulmonary emphysema: Recent studies targeted the NALP1 inflammasome [40], IL-6 [41], and chemotactic protein [42] in efforts to significantly reduce inflammation in brain injury, myocardiac infarction, and pulmonary emphysema, respectively.